Skip to main content

Anesthesia, Spinal

2
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
1
Chloroprocaine Injection [Clorotekal]Phase 4
B. Braun
B. BraunGermany - Melsungen
1 program
1
Chloroprocaine Injection [Clorotekal]Phase 41 trial
Active Trials
NCT03967288Suspended27Est. Dec 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
B. BraunChloroprocaine Injection [Clorotekal]

Clinical Trials (1)

Total enrollment: 27 patients across 1 trials

NCT03967288B. BraunChloroprocaine Injection [Clorotekal]

Comparison of Clorotekal and Bupivacaine for Short Obstetric Surgery

Start: Oct 2019Est. completion: Dec 202527 patients
Phase 4Suspended

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.